Phase II multicenter open-label study of karenitecin in previously treated epithelial ovarian and primary peritoneal cancer: a Gynecologic Oncology Group Study |
| |
| Authors: | J.J. KAVANAGH,M.W. SILL&dagger ,P.T. RAMIREZ,D. WARSHAL&Dagger ,M.L. PEARL§ ,& M.A. MORGAN&# |
| |
| Affiliation: | Department of Gynecologic Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas;;Department of Gynecologic Oncology, GOG Statistical and Data Center, Buffalo, New York;;Department of Gynecologic Oncology, Cooper Hospital/University Medical Center, Camden, New Jersey;;Department of Gynecologic Oncology, University of New York at Stony Brook, Stony Brook, New York;;and Department of Gynecologic Oncology, University of Pennsylvania Cancer Center, Philadelphia, Pennsylvania |
| |
| Abstract: | |
| |
| Keywords: | epithelial ovarian cancer karenitecin primary peritoneal cancer |
|
|
